The literature examining the utility of beta blockers in the setting of acute coronary syndrome (ACS) to limit infarct size has produced conflicting results within and across treatment eras. Animal ...

This page lists all known medications that could potentially lead to 'Renal infarct' as a side effect. It's important to note that mild side effects are quite common with medications. The medication(s ...

In patients with acute stroke and a large infarct of unrestricted size, thrombectomy and medical care led to better functional outcomes and lower mortality compared with medical care alone, the ...

Prehospital pulse-dose glucocorticoid treatment in patients with ST-segment elevation myocardial infarction (STEMI) does not reduce the final infarct size at 3 months but may improve acute outcomes ...

Please provide your email address to receive an email when new articles are posted on . High-dose oral colchicine during reperfusion and for 5 days failed to reduce infarct size in patients with STEMI ...

Life-threatening cardiac arrhythmias often occur after a heart attack, as the scar tissue can interfere with the spread of electrical impulses that activate the heart. Scientists have now developed a ...

In patients with ST-segment elevation myocardial infarction (STEMI), the use of percutaneous coronary intervention (PCI) to restore blood flow in an infarct-related coronary artery improves outcomes.

Silent cerebral infarcts are the most common neurologic injury in children with sickle cell anemia and are associated with the recurrence of an infarct (stroke or silent cerebral infarct). We tested ...

Among patients with anterior ST-segment elevation myocardial infarction (STEMI), elevated white blood cell (WBC) count at baseline is a powerful independent predictor of infarct size as measured by ...